Clinical Trial Update: Relapse in Previously Irradiated Prostate Bed : Stereotactic Ablative Reirradiation Potentiated by Metformin [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating stereotactic ablative reirradiation for relapse in previously irradiated prostate bed, potentiated by metformin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Institut Cancerologie de l'Ouest | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: RECRUITING